Suggested remit - To appraise the clinical and cost effectiveness of autologous haematopoietic stem cell transplantation (AHSTC) for previously treated relapsing-remitting multiple sclerosis.
Status Awaiting development
Decision None selected
Process STA pre-2018
ID number 1111

Project Team

Project lead Michelle Adhemar

Email enquiries


Key events during the development of the guidance:

Date Update
01 May 2019 This topic was not referred after the scoping exercise, the block scoping report summarising our advice to the Department of Health and Social Care regarding not referring this topic for appraisal is available here
27 July 2018 - 24 August 2018 Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators
16 August 2017 This topic is delayed pending further information
17 May 2017 (00:00) Scoping workshop (London)
28 March 2017 Draft scope documents

For further information on our processes and methods, please see our CHTE processes and methods manual